Two children who received Zolgensma, a gene therapy produced by Swiss drugmaker Novartis to treat spinal muscular atrophy, have died from liver failure, the company said Friday.
Aug 12, 2022
0
13
Atrial fibrillation (AF) is a major risk factor for stroke, and for decades the anticoagulant warfarin was the standard treatment for lowering that hazard. However, numerous drug and food interactions make warfarin burdensome ...
Aug 9, 2022
0
4
A brain protein with high potential to delay or reverse the onset of Alzheimer's disease has been exploited by University of Otago researchers.
Aug 1, 2022
0
25
A new study presented today at the Society of NeuroInterventional Surgery's (SNIS) 19th Annual Meeting shows that artificial intelligence (AI) technology can identify when a patient is having a stroke caused by emergent large ...
Jul 28, 2022
0
10
July is Sarcoma Awareness Month, bringing attention to a group of cancers that begin in the bones or soft tissues of the body. There are more than 70 types of sarcoma, including bone cancer. Treatments for bone cancer include ...
Jul 13, 2022
0
4
Migraine headaches currently affect more than one billion people across the globe and are the second-leading cause of disability worldwide. Nearly one-quarter of U.S. households have at least one member who suffers from migraines. ...
Jul 12, 2022
0
9
Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent ...
Jun 2, 2022
0
3
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), ...
Jun 1, 2022
0
64
New evidence shows that people who have undergone gender-affirming hormone therapy report high grades of satisfaction with both the physical and psychological effects. A new study on this topic, carried out by researchers ...
May 23, 2022
2
27
The White House is planning for "dire" contingencies that could include rationing supplies of vaccines and treatments this fall if Congress doesn't approve more money for fighting COVID-19.
May 21, 2022
0
5
